Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …

Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of
melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective …

Hyaluronic acid (HA) is a naturally occurring polysaccharide which has been extensively
exploited in biomedical fields owing to its outstanding biocompatibility. Self‐assembly of HA …

Because peritoneal metastasis (PM) from ovarian cancer is characterized by non-specific
symptoms, it is often diagnosed at advanced stages. Pressurized intraperitoneal aerosol …

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is applied to treat unresectable
peritoneal metastasis (PM), an advanced, end-stage disease with a poor prognosis …

Hyaluronic acid (HA), also named hyaluronan, is an omnipresent component of the tissue
microenvironment. It is extensively used to formulate targeted drug delivery systems for …

Postoperative peritoneal adhesions occur in the majority of patients undergoing intra-
abdominal surgery and are one of the leading causes of hospital re-admission. There is an …

Intraperitoneal (IP) chemotherapy has shown promising efficacy in ovarian cancer with
peritoneal carcinomatosis (PC), but in vivo rapid clearance and severe toxicity of free …

Background Ovarian cancer is the most lethal gynecological cancer which is characterized
by extensive peritoneal implantation metastasis and malignant ascites. Despite advances in …

Current therapies for patients with peritoneal metastases (PM) are only moderately effective.
Recently, a novel locoregional treatment method for PM was introduced, consisting of a …